The new program, which begins in January 2025, provides members support for navigating utilization management requirements ...

It seems like a day doesn’t go by without another positive finding for the glucagon-like peptide 1 (GLP-1) receptoragonist ...

An Ohio State University survey found that many adults are hesitant about getting flu, COVID-19, pneumococcal and respiratory ...

Researchers are studying how leukocyte telomere length may be associated with the progression of Friedreich's ataxia.

Segesterone acetate is a laboratory-made derivative of progesterone, a sex hormone used in many hormonal contraceptives ...

After the COVID-19 pandemic subsided, children who were hospitalized for respiratory syncytial virus infections were older ...

Ocrevus Zunovo can be administrated by providers twice a year with a 10-minute subcutaneous injection. There is no word yet ...

Many provisions of the Affordable Care Act are popular and the healthcare reform law has brought the proportion of Americans ...

Out of the three stages of menopause, perimenopausal women living with HIV experience the worst COVID-19 symptoms, possibly ...

This analysis finds that 57.4 million adults under the age of 65 could potentially be eligible for GLP-1 drugs based on ...

ARS Pharmaceuticals Inc. submitted a supplemental New Drug Application (sNDA) for a1 mg dose of nasal spray neffy, to treat ...

The Inflation Reduction Act’s limit on Medicare Part D spending can lead to savings for patients prescribed oral chemotherapy ...